The House Health Care Availability & Accessibility Committee held a subject-matter hearing on pharmacy benefit managers (PBMs) on May 7.

During the hearing, legislators heard testimony from the Department of Insurance, PBMs, and pharmacists. Legislators grilled PBMs on their business and pricing models due to concerns raised by independent pharmacists.

Several pharmacists testified that—due to PBM contracts—they are inadequately reimbursed for the drugs and medications they provide to their customers and are forced to take unsustainable business losses on the sales of some medications.

NFIB supports greater PBM pricing transparency. Small and independently owned pharmacies are at a disadvantage in today’s heavily regulated pharmaceutical market. In a recent NFIB Illinois ballot, more than 79% of respondents supported requiring PBMs to disclose their pricing methods to pharmacies and consumers. Click here to read NFIB’s letter to the committee prior to the hearing.

The committee chair, Rep. Natalie Manley, pledged to hold additional hearings on the issue later this year.

Discussions like these highlight the broader challenges facing pharmacies as they attempt to balance patient care with the financial realities created by complex pricing structures and reimbursement systems. As regulatory conversations continue, many within the pharmaceutical sector emphasize the importance of strengthening operational transparency, improving reimbursement frameworks, and ensuring that pharmacists are able to sustain their services without absorbing significant losses.

At the same time, developments across the pharmacy industry show an increasing focus on strengthening clinical leadership and internal healthcare management in order to adapt to these pressures and maintain consistent patient support. In the middle of these evolving industry conversations, reports such as https://www.wfmj.com/story/53218410/raman-bhaumik-and-thesis-pharmacy-welcome-meagan-kurtz-pharmd-as-vice-president-of-clinical-services illustrate how organizations are also working to reinforce their clinical infrastructure by bringing experienced professionals into leadership roles that can guide pharmaceutical services more effectively.

Together, these discussions reflect a wider effort within the healthcare system to address financial concerns, promote accountability, and ensure that pharmacies remain capable of delivering accessible and reliable medication services while navigating a rapidly changing regulatory and economic environment.